Literature DB >> 27372225

Risk factors for the development of active methicillin-resistant Staphylococcus aureus (MRSA) infection in patients colonized with MRSA at hospital admission.

Jose Cadena1, Josephine Thinwa2, Elizabeth A Walter3, Christopher R Frei4.   

Abstract

BACKGROUND: Patients who present to Veterans Affairs hospitals are screened for methicillin-resistant Staphylococcus aureus (MRSA) colonization. Those who test positive are isolated during their hospital stay. However, it is unknown which of these patients are most likely to subsequently develop active MRSA infections.
METHODS: This retrospective case-control study characterized risk factors for active MRSA infection among patients colonized with MRSA at hospital admission. Potential demographic and clinical risk factors were identified using electronic queries and manual chart abstraction; data were compared by standard statistical tests, and variables with P ≤ .05 in bivariable analysis were entered into a multivariable logistic regression model.
RESULTS: There were 71 cases and 213 controls. Risk factors associated with MRSA infection included diabetes mellitus with or without end organ damage (26% vs 14%, P = .02), hemiplegia (9% vs 2%, P = .01), chronic kidney disease (33% vs 20%, P = .03), postcolonization inpatient admission within 90 days (44% vs 29%, P = .03), surgery (41% vs 9%, P < .01), and dialysis (10% vs 3%, P = .02). On multivariable analysis, surgery during follow-up, dialysis during follow-up, and hemiplegia remained significant.
CONCLUSIONS: Among patients with MRSA colonization, surgery or dialysis during follow-up and history of hemiplegia were associated with subsequent MRSA infection. Knowledge of these risk factors may allow for future targeted interventions to prevent MRSA infections among colonized patients. Published by Elsevier Inc.

Entities:  

Keywords:  Active surveillance; MRSA; dialysis; hemiplegia

Mesh:

Year:  2016        PMID: 27372225     DOI: 10.1016/j.ajic.2016.05.009

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  7 in total

1.  Methicillin-Resistant Staphylococcus aureus Contamination of Frequently Touched Objects in Intensive Care Units: Potential Threat of Nosocomial Infections.

Authors:  Dharm Raj Bhatta; Sumnima Koirala; Abha Baral; Niroj Man Amatya; Sulochana Parajuli; Rajani Shrestha; Deependra Hamal; Niranjan Nayak; Shishir Gokhale
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-05-21       Impact factor: 2.585

2.  Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses.

Authors:  Kevin T Kavanagh
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-19       Impact factor: 4.887

3.  Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers.

Authors:  A Farkas; F Lin; K Bui; F Liu; G L An; A Pakholskiy; C F Stavropoulos; J C Lantis; A Yassin
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

4.  Do patients need advice and information to prevent infections - results of a single centre structured survey.

Authors:  M Voigt; R Schaumann; F Barre; E Mayr; W Lehmann; T Hawellek; H E J Kaba; S Wüstefeld; S Scheithauer
Journal:  Infect Prev Pract       Date:  2022-08-01

5.  View point: gaps in the current guidelines for the prevention of Methicillin-resistant Staphylococcus aureus surgical site infections.

Authors:  Kevin T Kavanagh; Said Abusalem; Lindsay E Calderon
Journal:  Antimicrob Resist Infect Control       Date:  2018-09-18       Impact factor: 4.887

6.  Effects of the proportion of high-risk patients and control strategies on the prevalence of methicillin-resistant Staphylococcus aureus in an intensive care unit.

Authors:  Farida Chamchod; Prasit Palittapongarnpim
Journal:  BMC Infect Dis       Date:  2019-12-03       Impact factor: 3.090

7.  The microbiology of diabetic foot infections: a meta-analysis.

Authors:  Katherine E Macdonald; Sophie Boeckh; Helen J Stacey; Joshua D Jones
Journal:  BMC Infect Dis       Date:  2021-08-09       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.